Cabozantinib Response in ETV6-NTRK3 G623R Positive Carcinoma HIPO-021
We report a case of marked response to cabozantinib in a secondary entrectinib-resistant tumor harboring the ETV6-NTRK3 fusion with a G623R solvent-front mutation.
- Type: Other
- Archiver: European Genome-Phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001006243 | HiSeq X Ten | 2 |
| Publications | Citations |
|---|---|
|
Response to Cabozantinib Following Acquired Entrectinib Resistance in a Patient With ETV6-NTRK3 Fusion-Positive Carcinoma Harboring the NTRK3G623R Solvent-Front Mutation.
JCO Precis Oncol 5: 2021 PO.20.00278 |
1 |